In September 2024, Roche, secured FDA approval for an injectable form of its blockbuster multiple sclerosis treatment, Ocrevus, reducing patient treatment time and potentially helping the company stay ...
On Tuesday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.58 which represents a decrease of $-2.15 or -2.13% from the prior close of $100.73. The stock opened at $100.76 and touched ...
Strategically, the company continues to focus on expanding its cell engineering platform, adding 25 new programs and securing major deals, including expanding its collaboration with Novo Nordisk and ...
Zentalis Pharmaceuticals (ZNTL) announced changes to its executive leadership team to support the Company as it plans and executes ...
As one would expect for a gracefully aging institution, the aesthetic of Willamette Week has evolved over the ...
To make the analysis of genetics easier, the company's product line includes consumables, integrated systems, and analytical ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...
It also has co-op for up to four players, a new addition to the series. "Whether you’re bringing the experience of your previous adventures with you, or are new to the Subnautica games ...
Green’s sister, Ragine Williams, 30, does DEI reporting, recruiting, and outreach for the technology firm SEI. She agreed that coming together with other women was inspiring, even if some may have ...
Shares of Merck & Co. Inc. MRK inched 0.44% higher to $101.17 Thursday, on what proved to be an all-around mixed trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback